|
Product complaint # (b)(4).Additional information was requested, and the following was obtained: ¿ how was the product purchased? not purchased, it was found during offline law enforcement ¿ was the device used on a patient? if so, was there any patient consequence? no ¿ please clarify how is the product suspected (diversion, counterfeit, other)? please specify.-- suspected counterfeit as the time stamps are the same.The following information was requested, but unavailable: ¿ is there an indication of how the product was distributed? unk ¿ is there any indication of the source? unk ¿ based on the packaging, is there any indication of which market the original genuine product may have come from? unk investigation summary = > visual inspection was conducted on two samples that pertain to product code 1961, lot sme5481.For the file received from raritan.The samples were received at the raritan site to perform the analysis and determine if the complaint is related to a counterfeit product.According to the results, based on the device disintegrating when removed from the pouch the product could be a counterfeit.The packaging appeared consistent with surgicel fibrillar based on examination of the two submitted products.The device was consistent in construction and ir spectrum with surgicel orc, but also consistent with competitor ¿fibrillar¿ devices such as curacel fibrillar, gelita-cel fibrillar, and resorba fibrillar.Per the conditions of returned samples, no conclusion could be reached as to what caused the reported complaint.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Device history review = > "a manufacturing record evaluation was performed for the finished device batch and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|